Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients
Public ClinicalTrials.gov record NCT02159365. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Single Arm Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To explore whether Elotuzumab dose administration over approximately 60 minutes is feasible and safe.
Study identification
- NCT ID
- NCT02159365
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 84 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 8, 2014 (Actual)
- Primary completion
- Jun 30, 2016 (Actual)
- Completion
- Jul 11, 2018 (Actual)
- Last update posted
- Jul 16, 2019
2014 – 2018
United States locations
- U.S. sites
- 29
- U.S. states
- 12
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Acrc/Arizona Clinical Research Center, Inc. | Tucson | Arizona | 85715 | — |
| Highland Oncology Group | Fayetteville | Arkansas | 72703 | — |
| Comprehensive Blood And Cancer Center | Bakersfield | California | 93309 | — |
| California Cancer Associates for Research and Excellence | Encinitas | California | 92024 | — |
| Compassionate Cancer Res Grp | Fountain Valley | California | 92708 | — |
| Robert A. Moss, Md Facp, Inc. | Fountain Valley | California | 92708 | — |
| Loma Linda University Cancer Center | Loma Linda | California | 92354 | — |
| Pacific Cancer Care | Monterey | California | 93940 | — |
| Ventura County Hematology-Oncology Specialists | Oxnard | California | 93030 | — |
| Wellness Oncology & Hematology | West Hills | California | 91307 | — |
| James R. Berenson, MD, Inc. | West Hollywood | California | 90069 | — |
| Rocky Mountain Cancer Centers Llp | Denver | Colorado | 80218 | — |
| Cancer Specialists Of North Florida | Jacksonville | Florida | 32204 | — |
| Center For Cancer Care & Research | Lakeland | Florida | 33805 | — |
| Baptist Health Medical Group Oncology | Miami | Florida | 33176 | — |
| Oncology Specialists,S.C | Park Ridge | Illinois | 60068 | — |
| Investigative Clinical Research Of Indiana, Llc | Indianapolis | Indiana | 46260 | — |
| Horizon Oncology Research, Inc | Lafayette | Indiana | 47905 | — |
| Clinical Research Alliance, Inc. | New York | New York | 10021 | — |
| St Francis Hospital | Greenville | South Carolina | 29607 | — |
| Greenville Health System | Greenville | South Carolina | 29615 | — |
| Texas Oncology | Dallas | Texas | 75231 | — |
| Baylor Charles A. Sammons Cancer Center | Dallas | Texas | 75246 | — |
| Local Institution | Houston | Texas | 77090 | — |
| Cancer Centers of South Texas | San Antonio | Texas | 78229 | — |
| Blood & Cancer Center of East Texas | Tyler | Texas | 75701 | — |
| Texas Oncology-McAllen South Second Street | Weslaco | Texas | 78596 | — |
| Blue Ridge Cancer Care | Blacksburg | Virginia | 24060 | — |
| Vista Oncology Inc., PS | Olympia | Washington | 98502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02159365, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 16, 2019 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02159365 live on ClinicalTrials.gov.